100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada
logo-home
Concise summary of the Cardiovascular System $9.91   Añadir al carrito

Resumen

Concise summary of the Cardiovascular System

2 reseñas
 72 vistas  0 veces vendidas
  • Grado
  • Institución
  • Book

Detailed summary of the cardiovascular chapter of BNF

Vista previa 2 fuera de 11  páginas

  • No
  • Chapter 2 - cardiovascular system
  • 4 de noviembre de 2020
  • 11
  • 2020/2021
  • Resumen

2  reseñas

review-writer-avatar

Por: rubana8 • 2 año hace

review-writer-avatar

Por: ayodeledelrah • 2 año hace

Sry it was a typo my bad, really like this, have you got one for MEP to purchase?

reply-writer-avatar

Por: anmoll • 2 año hace

Only 1? Any reason?

reply-writer-avatar

Por: ayodeledelrah • 2 año hace

Traducido por Google

Typo

reply-writer-avatar

Por: anmoll • 2 año hace

Okay no worries. I think I do - will try and upload by the end of today. Thanks

reply-writer-avatar

Por: anmoll • 2 año hace

Hi, yes I do - please see under 'Summary of the MEP' and 'MEP: Summary of Controlled Drugs'. Hope you find them useful.

avatar-seller
2 – Cardiovascular System



Drug Tx options for rhythm control post-
Chapter 2 – cardioversion:
Cardiovascular System 1. Standard BB
2. Sotalol
3. Flecainide or propafenone – avoid in
ARRHYTHMIAS
ischaemic or structural heart disease
Ectopic beats – if spontaneous and in a normal 4. Amiodarone – if necessary, start 4 weeks
heart, Tx with beta-blockers is not required before and continue for up to 12 months
post-electrical cardioversion to increase
Atrial fibrillation
success of procedure and maintain rhythm
 If Tx fails to control symptoms, refer within
Tx for Paroxysmal AF
4 weeks and consider ablation strategies
1. Standard BB or dronedarone, sotalol,
 Review anticoagulation, stroke and bleeding
flecainide, propafenone or amiodarone
risk annually
2. ‘Pill-in-the-pocket’ – useful in Pts with
Acute presentation infrequent episodes. It involves taking
 All Pts with fatal haemodynamic instability flecainide or propafenone to self-treat an
caused by new-onset AF = emergency episode of AF
electrical cardioversion
Stroke prevention
 All Pts with non-fatal haemodynamic
instability = rate or rhythm control if onset Stroke risk:
is < 48 hours or uncertain
Urgent rate control = IV verapamil or a BB
Cardioversion
 If AF is present for >48hrs – electrical
cardioversion is preferred. Do NOT start
until Pt has been anticoagulated for at least
3 weeks. If not possible, use parenteral
Bleeding risk:
anticoagulation
 Pharmacological cardioversion = IV
amiodarone or flecainide acetate
Drug Tx
1st line = rate control except in Pts with new-
onset AF, atrial flutter suitable for ablation, AF
with a reversible cause or if rhythm control is
more suitable based on judgement
Atrial flutter
Rate control options:  Rate control = BB, diltiazem, verapamil,
1. Standard BB (not sotalol) digoxin
2. Verapamil or diltiazem  Rhythm control = electrical cardioversion,
3. Digoxin is only effective for controlling the pharmacological cardioversion, ablation
rate at rest hence use only in sedentary Pts
with non-paroxysmal AF. It’s also used in AF
with congestive heart failure

, 2 – Cardiovascular System


Paroxysmal supraventricular tachycardia arrhythmias or bradyarrhythmias unresponsive
 Usually terminates spontaneously or with to atropine
reflex vagal stimulation like Valsalva
Digoxin – useful for controlling ventricular
manoeuvre, immersing face in cold water or
response in persistent and permanent AF
carotid sinus massage
 Hypokalaemia predisposes Pt to digitalis
Arrythmias post MI toxicity – managed by K+ sparing diuretics
 Treat bradycardia with atropine. If
unresponsive, treat with adrenaline/e BLEEDING DISORDERS

Ventricular tachycardia Tranexamic acid – impairs fibrin dissolution
 Treat ASAP with immediate defibrillation Desmopressin – used in mild-to-mod
 If stable – treat with anti-arrhythmics haemophilia and von Willebrand’s disease
Torsades de pointes – ventricular tachycardia Etamsylate – reduces capillary bleeding in the
associated with a long QT syndrome. presence of a normal number of platelets; it
 Causes = drugs, hypokalaemia, severe doesn’t act by fibrin stabilisation
bradycardia and genetics.
 Tx = magnesium sulfate, beta blocker (not VENOUS THROMBOEMBOLISM
sotalol) or atrial pacing
RFs = low mobility, obesity, malignant disease,
 Avoid anti-arrhythmics (QT prolong risk)
H/O venous thromboembolism, thrombophilic,
Vaughn Williams classification of anti- pregnancy, post-partum, Pts aged >60 years
arrhythmics:
Mechanical prophylaxis: Stockings
- Class I = membrane stabilising drugs
 Provide graduated compression and calf
(lidocaine, flecainide) pressure of 14-15mmHg.
- Class II = beta blockers  Wear during day and night until mobile.
- Class III = amiodarone, sotalol  Avoid in acute stroke and PAD
- Class IV = CCBs (not DHP CCBs)
Pharmacological prophylaxis
Negative ionotropic effect of anti-arrhythmics  Start ASAP or within 14 hours of admission
can be additive. Hypokalaemia can enhance the  RFs for bleeding = acute stroke, etc
arrhythmogenic effect of many drugs  If bleeding risk, only receive
Supraventricular arrhythmias pharmacological prophylaxis if risk of VTE is
 Adenosine = preferred Tx greater than risk of bleeding
 Digoxin = slows ventricular response Surgical Pts
 Verapamil = initial IV dose may be followed
by oral Tx. AVOID in AF in Wolff-Parkinson-  Offer mechanical prophylaxis to Pts with
White syndrome and children major trauma or surgery. Continue until Pt
 Beta blocker (e.g. esmolol, propranolol) – is mobile or discharged from hospital (or for
for rapid control of ventricular rate 30 days in spinal injury, spinal surgery or
cranial surgery)
Supraventricular and ventricular arrhythmias  Offer pharmacological prophylaxis (LMWH,
 Amiodarone – useful when another Tx fails. unfractionated heparin to Pts undergoing
It has a very long half-life. general or orthopaedic surgery
Digoxin-specific antibody – indicated for Tx of  Pharmacological prophylaxis in general
digoxin toxicity associated with ventricular surgery should continue for at least 7 days
post-surgery or until mobile. Extend

Los beneficios de comprar resúmenes en Stuvia estan en línea:

Garantiza la calidad de los comentarios

Garantiza la calidad de los comentarios

Compradores de Stuvia evaluaron más de 700.000 resúmenes. Así estas seguro que compras los mejores documentos!

Compra fácil y rápido

Compra fácil y rápido

Puedes pagar rápidamente y en una vez con iDeal, tarjeta de crédito o con tu crédito de Stuvia. Sin tener que hacerte miembro.

Enfócate en lo más importante

Enfócate en lo más importante

Tus compañeros escriben los resúmenes. Por eso tienes la seguridad que tienes un resumen actual y confiable. Así llegas a la conclusión rapidamente!

Preguntas frecuentes

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

100% de satisfacción garantizada: ¿Cómo funciona?

Nuestra garantía de satisfacción le asegura que siempre encontrará un documento de estudio a tu medida. Tu rellenas un formulario y nuestro equipo de atención al cliente se encarga del resto.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller anmoll. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for $9.91. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

45,681 summaries were sold in the last 30 days

Founded in 2010, the go-to place to buy summaries for 14 years now

Empieza a vender
$9.91
  • (2)
  Añadir